Cardiologist shares how weight loss medications may impact cardiovascular health.

"Structural Analysis of Membrane-associated Forms of Helicobacter pylori VacA Toxin," has been published in the Journal of Molecular Biology

U-M Medical School features Brittany Salazar's journey, which led her to become a graduate student in Puck Ohi's Lab.

CDB ranks #6 among similar departments nationwide in NIH research awards.

"Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking," has been published in the Journal of Cell Biology.

It showed high levels of accuracy at predicting death, major bleeding events and the need for blood transfusion. Visit Health Lab to read the full story. The BMC2 Probability of Events Following PCI application can be found here.

Researchers at Michigan Medicine developed an AI-driven algorithm that accurately predicts death and complications after PCI — which could emerge as a tool for clinicians as they determine treatment for blocked heart arteries.

Researchers and clinicians at the U-M Health Frankel Cardiovascular Center began sending reconditioned pacemakers to low- and middle-income countries for compassionate use cases in 2010 through the “My Heart Your Heart” program.

The Flourish recharge room, an innovative gift given to Michigan Medicine, provides staff with a transformative and healing experience.

"Neuregulin 4 mediates the metabolic benefits of mild cold exposure by promoting beige fat thermogenesis," has been published in JCI Insight.

"Mapping morphogenesis and mechanics in embryo models," has been published in Nature Methods.

"Nuclear roles for non-lamin intermediate filament proteins," has been published in Current Opinion in Cell Biology.

At Michigan Medicine, a mother of eight kids underwent a heart transplant surgery through a process called donation after circulatory death, or DCD, which saved her life.

Hannah (Giger Lab) has been awarded an NIH F31.

The W.M. Keck Foundation has awarded $1.3M to Assistant Professor Ryan Baldridge, Biological Chemistry, and Corydon Ford Collegiate Professor Billy Tsai, CDB, to develop a next-generation protein degradation technology to revolutionize antiviral treatments for endoplasmic reticulum (ER) dysfunction.